This article is a correction to:
The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
Svetlana V. Belenkaya1,2,3
Iuliia A. Merkuleva2
Olga I. Yarovaya1,3*Varvara Yu Chirkova4Elena A. Sharlaeva4Daniil V. Shanshin2Ekaterina A. Volosnikova2
Sergey Z. Vatsadze5Mikhail V. Khvostov3Nariman F. Salakhutdinov3
Dmitriy Shcherbakov2,3,4*- 1Laboratory of Bionanotechnology, Microbiology and Virology, Novosibirsk State University, Novosibirsk, Russia
- 2State Research Center of Virology and Biotechnology VECTOR, Koltsovo, Russia
- 3Department of Medicinal Chemistry, N.N Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, Novosibirsk, Russia
- 4Department of Physical-Chemistry Biology and Biotechnology, Altay State University, Barnaul, Russia
- 5N.D Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia
A Corrigendum on
The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
by Belenkaya SV, Merkuleva IA, Yarovaya OI, Chirkova VY, Sharlaeva EA, Shanshin DV, Volosnikova EA, Vatsadze SZ, Khvostov MV, Salakhutdinov NF and Shcherbakov DN (2023). Front. Bioeng. Biotechnol. 11:1187761. doi: 10.3389/fbioe.2023.1187761
In the published article, there was an error in the Materials and methods section at the Paragraph 2.2. Plasmid name was displayed as “A commercially available plasmid pRK793 was used for TEV protease production”.
The correct statement is “A self-made plasmid pET-TEV was used for TEV protease production”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: E. coli bacteria, 3CL protease, TEV protease, RBD, SARS-CoV-2
Citation: Belenkaya SV, Merkuleva IA, Yarovaya OI, Chirkova VY, Sharlaeva EA, Shanshin DV, Volosnikova EA, Vatsadze SZ, Khvostov MV, Salakhutdinov NF and Shcherbakov D (2023) Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper. Front. Bioeng. Biotechnol. 11:1294266. doi: 10.3389/fbioe.2023.1294266
Received: 14 September 2023; Accepted: 03 October 2023;
Published: 06 November 2023.
Edited and reviewed by:
Jose Ruben Morones-Ramirez, Autonomous University of Nuevo León, MexicoCopyright © 2023 Belenkaya, Merkuleva, Yarovaya, Chirkova, Sharlaeva, Shanshin, Volosnikova, Vatsadze, Khvostov, Salakhutdinov and Shcherbakov. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Olga I. Yarovaya, ooo@nioch.nsc.ru; Dmitriy Shcherbakov, dnshcherbakov@gmail.com